Hope looms … a nasal spray may protect against corona – UAE urgent news

0
17



At a time when the new virus is still filling the world and occupying people, scientists continue their research to eliminate Corona, which swept the world about a year ago, and in the new, researchers at the University of Pennsylvania, in partnership with the biotechnology company Regeneron, are trying to develop a nasal spray that protects against Covid-19. The idea also lies in relying on the principle of gene therapy by introducing genetic material through the nose and throat into the cells …

At a time when the new virus is still filling the world and occupying people, scientists continue their research to eliminate Corona, which swept the world about a year ago.

In the new, researchers at the University of Pennsylvania, in partnership with the biotechnology company Regeneron, are trying to develop a nasal spray that protects against Covid-19.

The idea also lies in relying on the principle of gene therapy by introducing genetic material through the nose and throat into the cells that are brought in in response to the production of strong antibodies that prevent infection with the new Corona virus.

“The advantage of our approach is that you don’t need an efficient immune system for it to be effective,” University of Pennsylvania project leader Professor James Wilson told AFP.

For 6 months

And the method that has been tested on animals can protect against the new Corona virus for about six months with a single dose, according to scientists, and it is recorded in addition to future vaccinations.

It is noteworthy that the US government had contacted James Wilson, a pioneer in gene therapy, in February to see if his laboratory could use this rapidly expanding technology against Covid-19.

But his team was only able to move forward after Regeneron developed an innovative treatment based on a combination of synthetic antibodies.

And recently the FDA granted emergency clearance for this treatment, which has been used specifically to treat President Donald Trump.

In addition, the researchers hope that the spray will be able to make the infected nasal cells produce antibodies to Regeneron and thus prevent any infection of SARS-CoV-2 along the way to the lungs. They also investigate whether side effects might be fewer than those of the vaccines that are about to be approved.

The University of Pennsylvania and Regeneron plan to complete their animal testing by January before requiring the FDA to get a green light for a human test.

LEAVE A REPLY

Please enter your comment!
Please enter your name here